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Abstract
Background: Japanese Encephalitis virus (JEV) is a common cause of acute and epidemic viral encephalitis. JEV infection is
associated with microglial activation resulting in the production of pro-inflammatory cytokines including Interleukin-1 b (IL-
1b) and Interleukin-18 (IL-18). The Pattern Recognition Receptors (PRRs) and the underlying mechanism by which microglia
identify the viral particle leading to the production of these cytokines is unknown.
Methodology/Principal Findings: For our studies, we have used murine model of JEV infection as well as BV-2 mouse
microglia cell line. In this study, we have identified a signalling pathway which leads to the activation of caspase-1 as the key
enzyme responsible for the maturation of both IL-1b and IL-18 in NACHT, LRR and PYD domains-containing protein-3
(NLRP3) dependent manner. Depletion of NLRP3 results in the reduction of caspase-1 activity and subsequent production of
these cytokines.
Conclusion/Significance: Our results identify a mechanism mediated by Reactive Oxygen Species (ROS) production and
potassium efflux as the two danger signals that link JEV infection to caspase-1 activation resulting in subsequent IL-1b and
IL-18 maturation.
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Introduction
Microglia are the resident macrophages of the Central Nervous
System (CNS), which are monocytic in origin and migrate to the
CNS during early embryonic development [1,2]. Microglia are the
primary cells that drive the inflammatory response within this
organization of the body during neurodegenerative diseases as well
as other pathologies of the brain. Viral encephalitis is the most
common brain pathology and it is caused by a number of viruses
that invade this organ [3]. Japanese Encephalitis Virus (JEV), a
single-stranded RNA (ssRNA) virus, is one of the common
arboviruses that causes severe brain pathology [4] manifesting
with fever, headache, vomiting and signs of meningeal irritation
resulting in high mortality [5] and is responsible for a majority of
encephalitis cases in Asiatic region [6]. During infection in the
CNS, JEV initiates a potent inflammatory response including
microglial activation which subsequently results in the production
of several pro- and anti-inflammatory cytokines including IL-1b
and IL-18 [7,8]. Both IL-1b and IL-18 play an important role in
fever, septic shock and inflammatory diseases [9]. In CNS, these
cytokines are detrimental for neuronal health and an uncontrolled
regulation of their secretion could lead to bystander neuronal
damage [7] leading to neurological sequelae associated with JEV
infection. Understanding the pathway leading to the production of
IL-1b and IL-18 can be valuable for designing therapeutic
approaches to control the secretion of these cytokines. However,
the machinery responsible for IL-1b and IL-18 production by
microglia during JEV infection is not understood and therefore it is
critical to comprehend the mechanisms regulating the production
of these cytokines in response to JEV infection.
Like their peripheral counterparts, microglia express several PRRs
for the identification of viruses [3,10]. Toll-like receptors (TLRs)
recognize microbial as well as non microbial products including
lipopolysaccharide (LPS), urate crystals, collagen [11] as well as viral
pathogens [12,13] on the membrane surfaces. Other PRRs such as
helicase-domain-containing antiviral proteins, Retinoic acid induc-
ible gene-I (RIG-I) and Melanoma differentiation-associated gene 5
(MDA5) as well as Nod-like receptors (NLRs) identify the pathogen
intracellularly [10,14–16]. Several NLRs have been reported to be
involved in recognition of viruses by the cells of monocytic lineage
[17]. NLRs, in addition to identifying pathogen associated molecular
patterns (PAMPs), also necessitate the presence of other host derived
danger associated molecular patterns (DAMPs) [18–21]. However,
information on the role of NLRs during JEV pathology is lacking.
Among all the NLRs reported, NLRP3 is the most studied and best
characterized intracellular receptor [22]. Upon recognition of a
pathogen, NLRP3 interacts with an adaptor molecule, Apoptosis-
associated speck-like protein containing a CARD (ASC). ASC in
turn interacts specifically with procaspase-1 via their Caspase
Recruitment Domain (CARD) [23] thereby activating Caspase-1
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[24]. This complex termed as inflammasome further processes and
activates pro-IL-1b and pro-IL-18 to their mature forms, which then
mediate numerous innate and adaptive immune responses upon
secretion [25].
In addition to their involvement in several inflammatory [26]
and neurodegenerative diseases [27], NLRP3 is engaged in
mediating inflammation during viral infections. It is involved in
the identification of double-stranded DNA viruses like adenovirus
[20,28] and Varicella Zoster Virus [29] as well as several ssRNA
viruses including Sendai virus, Influenza viruses [19,25], enceph-
alomyocarditis virus and vesicular stomatitis virus [30]. Recent
studies have shown that NLRP3 is not only important for adaptive
immune response against Influenza virus [21,25], it also stimulated
the secretion of IL-1b and IL-18 via its M2 protein in primed
macrophages and dendritic cells [31]. Thomas et al previously
made similar observations that innate immunity was compromised
in Nlrp3 (2/2) and Casp (2/2) mice during Influenza A virus
infection [32] which indicates that NLRP3 plays an important role
in the identification of ssRNA viruses. However, the involvement
of NLRP3 in mediating the production of IL-1b and IL-18 in
response to JEV infection is not recognized. The goal of this
research was to understand the involvement of NLRP3 in
processing and maturation of caspase-1 and subsequent produc-
tion of IL-1b and IL-18 in response to JEV and also to unravel the
underlying molecular mechanisms involved in the production of
these pro-inflammatory cytokines in microglial cells.
Results
JEV induces IL-1b and IL-18 production in vivo
We wanted to know the magnitude of IL-1b and IL-18 secretion
in adult mice brain during JEV infection. Therefore, we infected
6–8 week old BALB/c mice with 56105 Plaque Forming Units
(PFU) for different time points. At the very onset, we measured the
levels of pro-inflammatory cytokines from JEV infected as well as
mock-infected mice brain (C) to confirm the establishment of
infection. We observed that all the three cytokines, tumor necrosis
factor- a (TNF-a), Chemokine (C-C motif) ligand 2 (CCL2) also
known as macrophage chemoattractant protein-1 (MCP-1) and
interleukin-6 (IL-6) were up regulated by several folds in infected
mice with respect to mock-infected animals (Fig. 1A). There was a
significant and gradual increase in TNF-a by 2.5-fold, 20-fold and
10-fold on 3 d, 5 d and 7 d post infection (d.p.i) respectively.
Similarly, there was a significant increase in CCL2 by more than
7-fold after 3 d of infection and more than 20-fold increase on 5
and 7 d.p.i. respectively (Fig. 1B). The levels of IL-6 also
significantly increased by more than 1.5-fold after 3 d.p.i. as well
as by 6-fold and 4-folds on after 5 and 7 days post infection
respectively, suggesting a robust inflammation upon JEV infection
in mice brain (Fig. 1C). We then carried out quantitative Real
Time-PCR (qRT-PCR) for IL-1b and IL-18 mRNA and observed
a significant increase in IL-1b mRNA levels at all the time points
with levels increasing by more than 2-folds on 3 and 5 d.p.i. upon
JEV infection (Fig. 1D). However, qRT-PCR analysis of IL-18
mRNA expression suggested that there was no significant increase
in their levels even after 7 days of infection (Fig. 1E). This
discrepancy would have affected the levels of these cytokines at
protein levels. We therefore wanted to estimate their protein levels.
To determine the changes in protein levels of IL-1b and IL-18,
we performed ELISA to measure the secretion of active IL-1b and
IL-18 proteins in mice brain upon JEV infection. We observed a
significant increase in IL-1b levels in mice brain upon JEV
infection in a time dependent manner (Fig. 1F). There was a
maximum increase in IL-1b levels by 110-folds which was
observed on 5 d post infection (Fig. 1F). In contrast to IL-18
mRNA levels, mature IL-18 protein levels significantly increased
in mice infected with JEV in a time-dependent manner (Fig. 1G).
In this case, the maximum increase was observed on 7 d.p.i. where
the IL-18 levels increased by more than 14-folds over that of
mock-infected control group (Fig. 1G). These observations reflect
that there is a significant upregulation of IL-1b and IL-18 in mice
brain upon JEV infection. The differences in IL-18 mRNA levels,
however did not correlate with that of its protein levels in the
current time point analysis.
JEV induces robust inflammation in vitro along with IL-1b
and IL-18 production
In order to validate the results obtained from mice brain and to
identify a mechanism for the secretion of inflammatory cytokines,
IL-1b and IL-18, we infected BV-2 mouse microglial cell line with 5
MOI dose of JEV. JEV replicates very well in BV-2 cells and can
productively infect these cells without any morphological alterations
[33]. BV-2 cells respond to JEV by secreting several pro-
inflammatory cytokines and chemokines [8]. Therefore, in order
to confirm the onset of inflammation, we measured the levels of pro-
inflammatory cytokines like TNF-a, CCL2 and IL-6 and found that
their levels increased significantly over mock-infected control
condition within 6 h of JEV infection. There was more than 13-
fold increase in TNF-a, 9-fold in CCL2 and approximately 90-fold
increase in IL-6 levels (Fig. 2A) upon JEV infection with respect to
mock-infected condition. This confirmed the activation of microglia
in response to the virus and was followed by qRT-PCR analysis for
IL-1b and IL-18 mRNA expression. Infection with JEV for 3 h
resulted in increased IL-1b and IL-18 mRNA levels in infected cells
with respect to mock-infected condition. We observed a significant
5-fold increase in IL-1b mRNA (Fig. 2B) and more than 2.5-fold
increase in IL-18 mRNA (Fig. 2C) upon JEV infection with respect
to mock-infected control. LPS+ATP is known to stimulate the
production of the transcripts of these cytokines, therefore, we used it
as a positive control.
In order to estimate the IL-1b and IL-18 protein levels, we
carried out ELISA from the total protein isolated from BV-2 cells.
We observed a significant 8-fold increase in IL-1b levels in JEV
condition over that of mock-infected control and also observed a
significant increase in LPS+ATP conditions (Fig. 2D). Similarly, IL-
18 cytokine levels were increased by more than 6-fold in JEV
condition along with a significant increase in LPS+ATP condition
with respect to mock-infected control (Fig. 2E). These results suggest
that both IL-1b and IL-18 transcript as well as mature protein levels
get up-regulated in BV-2 microglial cells upon JEV infection.
JEV induces caspase-1 activation in vivo and in vitro
As mentioned earlier, caspase-1 is synthesized as an inactive
preprotein [24] which is converted to the active form after
cleavage of its C-terminus [34]. Production of mature IL-1b and
IL-18 requires the activation of caspase-1 enzyme which cleaves
immature pro- IL-1b and pro-IL-18 in response to inflammatory
agents [19]. We therefore wanted to know if activation of caspase-
1 occurred upon JEV infection both in BV-2 cells as well as in
mice brain. Using caspase-1 activity assay, we observed a
significant caspase-1 activity in JEV infected mice brain over that
of mock-infected control brain. There was a significant 2-fold
increase in caspase-1 activation on 3 d post infection. Even after 5
days of infection, we observed more than 1.5-folds increase in
caspase-1 activity over that of mock-infected mice brain (Fig. 3A)
and the levels gradually decreased thereafter. We did not observe
any significant change in caspase-1 activity in mice brain after 7
days of JEV infection. Similarly, upon JEV infection in vitro, we
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observed an increase in caspase-1 activity. We observed a time
dependent increase in its activity by 3 h and 6 h post infection
withmaximum activity being observed after 6 h of treatment by
both LPS+ATP as well JEV (Fig. 3B). To the best of our
knowledge, this is the first report of caspase-1 activation during
JEV infection in mice brain and microglial cells.
Replicating JEV and not the host derived factors are
responsible for caspase-1 activity and subsequent
production of IL-1b and IL-18
In order to rule out the possibility of caspase-1 activation by host
derived factors, we used mice brain homogenate from control mice
(Ctrl) to treat BV-2 cells along with homogenates from JEV treated
mice (JEV) and carried out the caspase-1 activity assay and
measured IL-1b and IL-18 in these cells. We also treated BV-2
cells with UV irradiated homogenates from JEV treated mice
brain (UV-JEV) in order to confirm the role played by replication
competent JEV in mediating the cytokine production. We found
that UV irradiation significantly affected the plaque formation by
JEV (Fig S1A) suggesting the altered replication efficiency of the
virus. We observed no significant activity of caspase-1 in either
Ctrl or UV-JEV conditions with respect to JEV condition (Fig
S1B). Moreover, there was a significant decrease in the levels of
IL-1b (Fig S1C) and IL-18 (Fig S1D) in both, Ctrl and UV-JEV
Figure 1. JEV induces the production of IL-1b and IL-18 in vivo. Infection was carried out in BALB/c mice with 56105 PFU of JEV Intravenously.
Brain samples were isolated from mock-infected control (C) as well JEV infected mice after 3 d, 5 d and 7 d post infection. (A–C) Cytokine levels were
estimated using CBA. The graphs represent the levels of pro-inflammatory cytokines, TNF-a, CCL2 and IL-6 in pg/ml from protein homogenates
isolated from infected and mock-infected mice brain (D–E) qRT-PCR analysis was carried out from total RNA isolated from mock-infected and JEV
infected mice brains on all the time points and levels of IL-1b as well as IL-18 mRNA were measured. Graphs represent fold change in mRNA values
with respect to mock-infected control normalized to 18 s rRNA internal control. (F–G) ELISA study was carried out to measure the levels of mature IL-
1b and IL-18 cytokine from JEV infected as well as uninfected brain samples. Graphs represent the cytokine levels in pg/ml in mock-infected control
as well as infected brain samples. Data represent mean 6 SEM of 5 animals in each group. Statistical differences were evaluated using one way
ANOVA with Bonferroni’s post hoc test. *, **, Statistical differences in comparison to mock-infected control values (* p,0.05; ** p,0.01).
doi:10.1371/journal.pone.0032270.g001
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Figure 2. JEV induces the production of IL-1b and IL-18 in vitro. BV-2 microglial cells were infected with 5 MOI of JEV for different time points.
LPS+ATP condition was used as a positive control for qRT-PCR, ELISA and caspase-1 activity studies. (A) Cytokine analysis from mock-infected control
and JEV infected BV-2 cells was carried out after 6 h of JEV infection using cytokine bead array. Graphs represent the levels of pro-inflammatory
cytokines, TNF- a, CCL2 and IL-6 after JEV infection with respect to mock-infected control condition. (B–C) qRT-PCR studies on total RNA isolated from
uninfected cells as well as on BV-2 cells infected with JEV for 3 h. IL-1b and IL-18 mRNA levels are represented in terms of fold change with respect to
mock-infected control normalized to 18 s rRNA internal control. (D–E) Levels of mature IL-1b and IL-18 cytokines upon JEV infection with respect to
mock-infected control condition were measured by ELISA. Graphs represent the fold change values in JEV infected cells with respect to mock-
infected control condition. Data represent mean 6 SEM from 3 independent experiments performed in duplicate. Statistical differences were
evaluated using one way ANOVA with Bonferroni’s post hoc test. *, **, Statistical differences in comparison to mock-infected control values (* p,0.05;
** p,0.01).
doi:10.1371/journal.pone.0032270.g002
Figure 3. JEV induces caspase-1 activation in vivo and in vitro. Infection was carried out in BALB/c mice with 56105 PFU of JEV Intravenously.
Brain samples were isolated from mock-infected control (C) as well JEV infected mice after 3 d, 5 d and 7 d post infection for estimation of caspase-1
activity. (A) Caspase-1 activity is represented as fold change in caspase-1 activity in JEV infected brain with respect to mock-infected brain. Data
represent mean 6 SEM of 5 animals in each group. (B) Caspase-1 activity was measured in BV-2 cells infected with 5 MOI of JEV after 3 h, 6 h and
12 h of JEV infection over that of mock-infected condition. Caspase-1 activity is represented as fold change with respect to mock-infected condition.
Data represent mean 6 SEM from 3 independent experiments performed in duplicate. Statistical differences were evaluated using one way ANOVA
with Bonferroni’s post hoc test. *, **, Statistical differences in comparison to mock-infected control values (* p,0.05; ** p,0.01).
doi:10.1371/journal.pone.0032270.g003
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condition when compared with JEV infected condition. These
findings suggest that replicating JE virus and not the replication
incompetent virus activates inflammasome complex in order to
initiate caspase-1 activity and subsequent production of IL-1b and
IL-18. In addition, these observations also suggest that host
derived factors from mock-infected mice brain homogenate do not
active this complex.
Caspase-1 activity is required for production of IL-1b and
IL-18 during JEV infection in vitro
In order to find out whether an active caspase-1 is required for
the maturation of IL-1b and IL-18 to their active forms in BV-2
cells upon JEV infection, we inhibited caspase-1 activity using the
caspase-1 inhibitor Z-YVAD-FMKYVAD (YVAD) and then the
cells were infected with JEV for 6 h as we had previously observed
a significant increase in caspase-1 activity at this time point. JEV
infection increased IL-1b and IL-18 levels significantly at this time
point (Fig. 4A & 4B). However, the inhibition of caspase-1 activity
(data not shown) resulted in significant decrease in both IL-1b
(Fig. 4A) and IL-18 (Fig. 4B) levels by more than 2-folds. This
finding suggests that caspase-1 is crucial for the maturation of IL-
1b and IL-18 during JEV infection in mouse microglia.
Knockdown of NLRP3 decreases caspase-1 activity and
subsequent production of IL-1b and IL-18 upon JEV
infection
NLRP3 is one of the key inflammasome molecules implicated in
identification of ssRNA and double-stranded DNA viruses [19]. In
order to determine whether NLRP3 is required for caspase-1
maturation upon JEV infection, we first carried out SiRNA
mediated knockdown of NLRP3. We observed that in JEV
infected BV-2 cells, there was more than 2.5-fold induction in
NLRP3 mRNA levels with respect to mock-infected control
condition (Fig. 5A). Upon JEV infection, NLRP3 SiRNA
treatment(SiRNA+JEV) resulted in a significant decrease in
NLRP3 mRNA levels by about 50% confirming a substantial
knockdown of NLRP3 transcript while there was no change
observed in the cells transfected with scrambled RNA upon JEV
infection (ScRNA+JEV) with respect to JEV alone treatment
(Fig. 5A). In order to confirm that NLRP3 inflammasome is
required for caspase-1 maturation and its activity, we analyzed
caspase-1 activity in NLRP3 knockdown conditions upon JEV
infection. As hypothesized, we observed a significant reduction of
caspase-1 activity by 1.8-folds in SiRNA+JEV condition compared
to JEV alone condition (Fig. 5B). There was no change in caspase-
1 activity in ScRNA+JEV condition with respect to JEV alone
condition. We then carried out ELISA to measure IL-1b and IL-
18 expression levels under different conditions. We observed a 3-
fold reduction in IL-1b levels in SiRNA+JEV condition with
respect to the JEV alone condition (Fig. 5C). Similarly, IL-18 levels
were also significantly reduced by 2-folds upon JEV treatment in
NLRP3 knockdown condition with respect to JEV alone treatment
(Fig. 5D). This experiment is the first evidence of NLRP3
dependent IL-1b and IL-18 maturation in JEV infection. We
can conclude from our findings that NLRP3 is one of the key
mediators of host responses as it is crucial for the production of IL-
1b and IL-18 during JEV infection.
Generation of ROS is crucial for caspase-1 activity and
subsequent IL-1b and IL-18 production during JEV
infection
Requirement of ROS as a danger signal for inflammasome
complex formation has been reported by several workers [26]. We
therefore wanted to test if ROS generation plays a role in
inflammasome activation during JEV infection. We observed that
upon JEV infection, levels of ROS increased significantly by 8-fold
with respect to mock-infected control condition (Fig. 6A).
However, upon addition of DPI, a potent ROS-inhibitor, there
was a significant drop in ROS levels by 5-fold with respect to JEV
alone condition. We then determined caspase-1 activity during
viral infection upon DPI treatment. We observed that while there
was 2.5-fold increase in caspase-1 activity upon JEV infection, DPI
treatment in JEV infected cells resulted in a significant reduction
in caspase-1 activity with respect to JEV alone treatment (Fig. 6B).
This was followed by the estimation of downstream effects of
caspase-1 activity by ELISA studies which revealed that both IL-
1b (Fig. 6C) and IL-18 (Fig. 6D) levels were reduced significantly
by more than 2-folds upon DPI treatment along with JEV
infection. These findings suggest that generation of ROS during
JEV infection might acts as a stress signal for the inflammasome
complex formation which in turn is crucial for the production of
these cytokines.
Figure 4. Caspase-1 activity is required for the production of IL-1b and IL-18 during JEV infection. BV-2 cells were incubated with 5 mM
YVAD for 30 min to inhibit caspase-1 activity followed by JEV infection. (A–B) ELISA for IL-1b and IL-18 was carried out in JEV infected BV-2 cells upon
caspase-1 inhibition. The cytokine levels were then measured using ELISA and the values are represented in pg/ml. Data represent mean6 SEM from
3 independent experiments performed in duplicate. Statistical differences were evaluated using one way ANOVA with Bonferroni’s post hoc test.
**, Statistical difference in comparison to mock-infected control values (** p,0.01) and#, Statistical difference with respect to JEV infected condition
(p,0.01).
doi:10.1371/journal.pone.0032270.g004
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K+ efflux is critical for inflammasome activity as well as IL-
1b and IL-18 production during JEV infection in vitro
Inflammasome assembly requires secondary signals like danger
associated molecular patterns (DAMPs) which are host cell derived
and are generated in response to pathogens. DAMPs like ATP are
known to induce K+ efflux from the cells via P2X7 receptors.
Similarly, certain viruses are known to induce potassium efflux
triggering inflammasome activation [20]. Therefore, we infected
BV-2 cells with JEV along with or without Potassium Chloride
(KCl) in the culture medium in order to maintain excessive
extracellular potassium which will act as an inhibitor for K+ efflux
due to reversal of the concentration gradient. Interestingly, in the
presence of KCl, we observed more than 2-fold reduction in
caspase-1 activity with respect to JEV alone condition (Fig. 7A).
This finding was further supported by significant reductions in IL-
1b and IL-18 levels in presence of excess extracellular potassium
(Fig. 7B and 7C). Although, we did not observe a complete
abrogation of these cytokines upon KCl treatment, these findings
suggest that NLRP3 inflammasome activation may require
potassium efflux as an additional danger signal upon JEV
infection.
Discussion
Our lab has previously shown that microglia respond to JEV
infection by secreting the pro-inflammatory IL-1b and IL-18 in
addition to other proinflammatory cytokines [7,35]. IL-1b is a
multifunctional cytokine with important roles in acute and chronic
inflammation [36,37] which can trigger signal transduction
pathways resulting in synthesis of additional pro-inflammatory
cytokines, chemokines and acute phase proteins thereby causing
fever, and hypotension [38]. Furthermore, over production of
these cytokines is associated with bystander neuronal death during
JEV infection [7]. Therefore, it is important to keep the levels of
these cytokines under control and tightly regulated manner. In
stark contrast to the available knowledge regarding microglial
activation in response to JEV, the information regarding the
Figure 5. NLRP3 is critical for caspase-1 activity as well as IL-1b and IL-18 production. Transient knockdown of NLRP3 using 100 nM of
NLRP3 SiRNA was carried out in BV-2 microglial cells. Scrambed RNA (ScRNA) was used as a transfection control. This was followed by virus infection
with 5 MOI dose for 6 h. (A) NLRP3 mRNA levels were measured by qRT-PCR from total RNA isolated from JEV infected as well as uninfected BV-2
cells. The graph represent a fold change in NLRP3 mRNA with respect to mock-infected control normalised to 18 s rRNA internal control. (B) Caspase-
1 activity was also measured in NLRP3 knockdown condition upon JEV infection. Graph represents fold change in caspase-1 activity in different
conditions with respect to mock-infected control. (C–D) In order to measure IL-1b and IL-18 production, ELISA was then carried out in NLRP3
knockdown (SiRNA+JEV) condition with respect to JEV infected sample. Graph represents cytokine levels in pg/ml. Data represent mean 6 SEM from
3 independent experiments performed in duplicate. Statistical differences were evaluated using one way ANOVA with Bonferroni’s post hoc test.
*, **, Statistical difference in comparison to mock-infected control values (* p,0.05, ** p,0.01) and #, Statistical difference with respect to JEV
infected condition (p,0.01).
doi:10.1371/journal.pone.0032270.g005
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Figure 6. Generation of ROS is critical for caspase-1 activity and subsequent IL-1b and IL-18 maturation. BV-2 cells were incubated with
1 mM of DPI for inhibition of ROS generation. (A) Representative FACS plot showing intracellular ROS production, after 4 h of JEV infection and
representation of the Mean Fluorescent Intensities (M.F.I) (right graph) in mock-infected control (C), JEV+DPI and JEV alone condition. (B) Caspase-1
activity measured after 6 h of JEV infection in presence or absence of DPI. Graph represents fold change in caspase-1 activity with respect to mock-
infected control. (C–D) ELISA study showing the levels of mature IL-1b and IL-18 in JEV+DPI condition with respect to JEV alone infected sample.
Graph represents cytokine levels in pg/ml. For Potassium efflux study, BV-2 cells were incubated with 50 mM KCl for 20 min in order to study the
requirement of K+ efflux for caspase-1 activity and its downstream effects. Data represent mean 6 SEM from 3 independent experiments performed
in duplicate. Statistical differences were evaluated using one way ANOVA with Bonferroni’s post hoc test. *, **, Statistical difference in comparison to
mock-infected control values (*p,0.05, ** p,0.01) and #, Statistical difference with respect to JEV infected condition (p,0.01).
doi:10.1371/journal.pone.0032270.g006
Figure 7. Potassium efflux is required for caspase-1 activity and subsequent inflammation upon JEV infection. (A) Caspase-1 activity
was measured in presence of KCl upon JEV infection. Graph represents caspase-1 activity in JEV infected cells incubated with KCl with respect to
untreated JEV alone condition. (B–C) ELISA study showing the levels of IL-1b and IL-18 in KCl treated condition upon JEV infection over that of JEV
alone condition. Graph represents IL-1b and IL-18 levels in pg/ml. Data represent mean 6 SEM from 3 independent experiments performed in
duplicate. Statistical differences were evaluated using one way ANOVA with Bonferroni’s post hoc test. *, **, Statistical difference in comparison to
mock-infected control values (*p,0.05, ** p,0.01) and #, Statistical difference with respect to JEV infected condition (p,0.01).
doi:10.1371/journal.pone.0032270.g007
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machinery responsible for the production of IL-1b and IL-18
remains elusive. Our current study focused on the identification of
the molecular mechanism for the production of pro-inflammatory
cytokines IL-1b and IL-18 during JEV infection in microglia. Our
findings demonstrated for the first time that in response to JEV
infection, (i) there is an activation of caspase-1 both in vitro and in
vivo, (ii) NLRP3 is the key mediator of caspase-1 activity and IL-1b
and IL-18 production in microglial cell and (iii) generation of ROS
and potassium efflux are the supplementary danger signals that are
required by microglial cell for IL-1b and IL-18 production.
According to a recent study for the development of a nanoparticle
based approach for increasing the vaccine efficacy against West Nile
Virus, induction of NLRP3 inflammasome resulted in the enhanced
potency of this vaccine [39]. While this finding indirectly suggested
an involvement of NLRP3 in mediating innate immune response
against a flaviviral species, there is no existing literature directly
implicating the role of inflammasome in their infection. More
recently, transcriptome analysis during JEV pathology showed an
increased levels of caspase-1 along with the adaptor molecule,
Pyrin-containing caspase recruitment domain or ASC at the
transcript level in mice brain [40]. Based on these reports, we
hypothesized that NLRP3 might be involved in mediating the
inflammasome complex formation during JEV infection. Our study,
therefore, focused on the role played by microglia in combating JEV
infection and unravels a novel PRR for the identification of this
virus. Our findings show that there is a robust inflammation in
microglia upon JEV infection which is accompanied by an increased
production of IL-1b and IL-18 both in vitro and in vivo. We used
LPS+ATP as a positive control for the in vitro cytokine expression
and caspase-1 activity experiments. LPS induces the production of
pro-forms of these cytokines, while ATP potentiates this response by
acting as a danger signal and ensuring the maturation of these
cytokines resulting in an increased expression of both the caspase-1
activity as well as IL-1b and IL-18 cytokines. While we did not
observe any increase in the pro-IL-18 mRNA in the JEV treated
brain samples up to 7 days after infection, we observed a significant
increase in IL-18 protein levels in these brain samples. It is quite
likely that caspase-1 cleaves the already present IL-18 pre-protein to
its mature forms in spite of no significant increase in pro-IL-18
mRNA. Indeed, we observed enhanced caspase-1 activity in mice
brain as well in microglial cells upon JEV infection. The increase in
caspase-1 activity by 2.5 folds seems to be physiologically important
in our case as this enhancement is critical for substantial production
of mature IL-1b and IL-18. Similar levels of caspase-1 activity were
obtained in a study involving anakinra administration to arthritis
patients where caspase-1 activity increased by 1.5 folds in absence of
anakinra in the blood samples of patients with respect to healthy
subjects [41] suggesting the physiological relevance of 2-fold
increase in caspase-1 activity. The role of caspase-1 is important
in the maturation of inflammatory cytokines as inhibition of
caspase-1 activity with YVAD prior to JEV infection resulted in
significant reduction of IL-1b and IL-18. Furthermore, our findings
confirm that NLRP3 is a key NLR which recruits pro-caspase-1 into
the inflammasome complex and subsequent cleavage of the pro-
inflammatory IL-1b and IL-18 during JEV infection.
Several reports in the past have suggested that ROS generated by
almost all the activators of NLRP3, plays a major role in the activation
of NLRP3 inflammasome activation [26,42,43]. We therefore
estimated ROS generation upon JEV infection and observed a
significant increase in their levels upon infection. Pre-treatment of BV-
2 cells with a ROS inhibitor, DPI, resulted in reduction of caspase-1
activity as well as expression of IL-1b and IL-18 cytokines. The
mechanism of ROS mediated NLRP3 inflammasome activation is
however, not fully understood. Initially phagosome associated
NADPH oxidases were thought to be the primary sources of reactive
oxygen superoxide ions upon phagocytosis of the inflammasome
activators [26]. But studies in Chronic Granulomatous Disease (CGD)
patients with mutations in four subunits of NADP oxidase complex
show that despite the absence of ROS production, they have
increased levels of caspase-1 activity and pro-inflammatory cytokine
generation [44]. Infact, some recent reports suggest that mitochondria
could be the main source of ROS for inflammasome activation
[45,46]. So, though in case of JEV, we show the addition of ROS
inhibitor impairs the pro-inflammatory cytokine production, the
source and mechanism as to how ROS activates NLRP3 inflamma-
some in response to JEV infection still needs to be elucidated.
Previous studies have also shown that high intracellular
concentration of K+ ions can potentially inhibit NLRP3 inflamma-
some activation [47]. It is well documented that ATP binds to P2X7
receptors on macrophages and subsequently results in association of
P2X7 receptors with pannexin 1 and formation of a non-selective
pore [48]. It has been previously demonstrated that Adenovirus
induced NLRP3 inflammasome activation is hindered in the
presence of potassium channel inhibitors like glyburide or excess
KCl in the media thus inhibiting K+ ion efflux [28]. In case of
influenza virus, M2 protein, a proton-selective ion channel causes
NLRP3 inflammasome activation by causing H+ ion export from
golgi complex [31]. It is also suggested that this ion channel activity
may also result in imbalance of other ions like Na+ and K+ thus
resulting in inflammasome activation. Our data suggests that
NLRP3 inflammasome activation upon JEV infection requires K+
ion efflux as an additional danger signal, however the exact
mechanism by whichK+ ion efflux may be resulting is still unknown.
The discovery of mitochondria as the organelle playing a major role
in NLRP3 inflammasome activation leads to speculations that K+
ion channels on the mitochondria may be controlling the levels of
intracellular K+ ions and control inflammasome activation.
However, further studies are required to understand the detailed
mechanism of K+ efflux during JEV infection and the underlying
mechanism for inflammasome aggregation.
Our study identifies the role of NLRP3 inflammasome mediated
caspase-1 activation and subsequent IL-1b and IL-18 production
during JEV infection. We have also shown that replication
competent JEV is crucial for activating this complex as UV treated
JEV does not increase caspase-1 activity or the production of
inflammatory cytokines. Although, the PAMPs associated with
JEV recognized by host cells are not fully recognized, our data
with UV studies suggest that inflammasome complex may identify
the ssRNA genome of JEV (Fig S1) which may result in its
activation. The activation of inflammasome complex in response
to JEV is shown in the schematic representation (Fig. 8). We
propose that upon detection of viral PAMPs, pro-caspase-1
undergoes auto-catalytic cleavage and activation, thus releasing
active caspase-1. Active caspase-1 cleaves pro- IL-1b and IL-18
thus resulting in the secretion of their active forms. The generation
of ROS and K+ ion efflux also play a major role in the activation
of NLRP3 inflammasome upon JEV infection as shown in the
schematic (Fig. 8). Detailed studies are required to understand in
detail the pathogenic signatures of JEV which are identified by
NLRP3 intracellularly. NLRP3 can be a potential target for
therapeutic intervention and this information can lead to new
antiviral therapies and to new insights for treating JEV infection.
Materials and Methods
Ethics Statement
The animals were handled in strict accordance with good
animal practice guidelines defined by the Institutional Animal and
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Ethics Committee (IAEC) of National Brain Research Centre and
the Committee for the Purpose of Control and Supervision of
Experiments on Animals (CPCSEA), Ministry of Environment and
Forestry, Government of India. The animal experiment protocol
approval numbers were NBRC/IAEC/2007/36 and NBRC/
IAEC/2008/41. All animal studies were approved by the IAEC of
National Brain Research Centre.
Virus stock, titration and Ultraviolet (UV) irradiation of JEV
JEV isolates GP78 strain are routinely maintained and
propagated in BALB/c mouse pups as described earlier [49,50].
Briefly, suckling mice (3–4 days old) were inoculated with the virus
through intra-cerebral route and their brain tissue was harvested
when symptoms were visible. A 10% suspension of the brain tissue
was made by homogenization in the Minimal Essential Medium
(MEM). It was then centrifuged at 10,000 g to remove cellular
debris and filtered through a 0.22 mm sterile filter. The mouse
brain derived virus was stored at 270uC in small aliquots. We
used this aliquot as seed virus for further experimentation either
for in vivo or in vitro systems. JEV inactivation was carried out with
a UV crosslinker (UVC 500, Hoefer scientific, USA) using short-
wavelength UV radiation (UVC, 254 nm) at a distance of 5 cm for
10 min on ice as described earlier [51]. Inactivation of virus was
verified by plaque assay, indicating a reduction in its infectious
titre by more than 104 folds. Virus titration by plaque formation
was carried out on the monolayers of porcine kidney (PS) cell line.
PS cells were seeded in 35 mm dishes to give semi-confluent
monolayers in about 18 h. Monolayers were inoculated with
tenfold dilutions of virus sample made in MEM containing 1%
Fetal Calf Serum (FCS) and were incubated for 1 h at 37uC with
occasional shaking. The inoculum was removed by aspiration and
the monolayers were overlaid with MEM containing 4% FCS, 1%
low melting point agarose and a cocktail of antibiotic-antimycotic
solution (Gibco) containing penicillin, streptomycin and ampho-
tericin-B. Plates were incubated at 37uC for 3–7 days until plaques
were visible. To allow counting of the plaques, the cell monolayer
were stained with crystal violet after fixing the cells with 10%
formaldehyde [49].
Virus infection of animals
A previously described animal model of Japanese Encephalitis
[49] was used for in vivo studies. Briefly, five animals per group of
6–8 weeks old BALB/c mice of either sex were injected
intravenously (i.v.) with approximately 56105 plaque forming
units (PFU) of GP78 strain of JEV in 50 ml of 16Phosphate buffer
Saline (PBS) over a period of 3, 5 and 7 days. Mock-infected
control animals received the same amount of 16 PBS as the
experimental group. The animals of each time group were
sacrificed at different time points for either protein or RNA. From
the third day post infection, animals started to show symptoms of
encephalitis including limb paralysis, poor pain response and
whole body tremor.
Cell Culture and reagents
Mouse microglial cell line BV-2 was originally obtained from
Dr. Steve Levison, University of Medicine and Dentistry, New
Jersey, USA and maintained in the lab according as previously
described [52]. Briefly, BV-2 cells were grown at 37uC in
Figure 8. Schematic showing the signalling pathway leading to IL-1b and IL-18 production upon JEV infection in microglia. NLRP3 is
the key PRR involved in the identification of JEV intracellularly in a microglia. The NLRP3 interacts with an adaptor molecule, ASC and recruits pro-
caspase-1 forming a biochemical complex termed as inflammasome. In response to JEV, NLRP3 cleaves pro-caspase-1 into its active form, caspase-1.
Caspase-1 then cleaves the inactive pro-forms of IL-1b and IL-18 to their mature forms which are then secreted out. ROS and K+ efflux are the host
derived danger signals that are critical for the formation of NLRP3 biochemical complex during JEV infection.
doi:10.1371/journal.pone.0032270.g008
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Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented
with 5% Sodium Bicarbonate (NaHCO3), 10% Fetal Bovine
Serum (FBS), penicillin at 100 units/ml and streptomycin at
100 mg/ml. The reagents related to cell culture were obtained
from Sigma Aldrich, USA unless otherwise stated. At 70%–80%
confluence, the cultures were treated with accutase to dislodge the
microglial cells. The cells were seeded onto plastic petri dishes, and
the dishes were placed in a 37uC incubator for the cells to grow.
Infection of BV-2 cells with JEV and treatment with LPS
and ATP
The mouse microglial cell line BV-2 was plated in 90 mm
plastic petri dishes at the density of 1.56106 cells. After 15–18 hrs
incubation in 10% DMEM, the cells were incubated in serum free
media for 4–5 hrs. The cells were then adsorbed with UV-JEV
and/or JEV at an MOI of 5 for 1.5 hrs. After adsorption, the
unbound viruses were removed by washing gently with 16 PBS.
The cells were then incubated additionally in fresh serum free
media for 3 h for mRNA expression and 6 h for caspase-1 activity
and cytokine secretion. Virus titration was performed with this
supernatant to confirm the presence or absence of live viruses. For
positive control to caspase-1 activity and secretion of IL-1b and
IL-18 in vitro, stimulation with LPS (1 mg/ml) followed by
30 minutes exposure to 1 mM ATP was carried out. Mock-
treated control cells received only 1xPBS.
Measurement of reactive oxygen species (ROS) and
treatment with KCl
We determined the effect of JEV infection on microglial cells by
determining the levels of ROS as well as levels of pro-
inflammatory cyto/chemokines. Intracellular ROS generation in
control and treated cells was assessed using the cell permeable,
non-polar H2O2 sensitive dye 5-(and-6)-chlromethyl-29, 79-
dichlorodihydrofluorescein diacetate (CM-H2DCFDA) (Sigma
Aldrich) as described previously [53,54]. The extent to which
H2O2 is generated is defined as the extent of ROS generation
here. In order to understand the role of ROS formation in the
assembly of inflammasome, ROS inhibitor, 1 mM diphenyleneio-
donium chloride (DPI) (Sigma Aldrich,USA) was used. Briefly,
BV-2 cells were incubated for 4 h with 1 uM DPI (Sigma
Aldrich,USA) or 5 mM N-Acetyl Cysteine (NAC) (data not shown)
followed by mock and JEV infection for 1.5 h. This was further
followed with incubation in serum free media for 4 h. Upon
treatment, the cells were further treated with H2DCFDA (5 mM)
for 1 h at 376C, washed twice with 16 PBS, and fluorescent
intensity of the cells was measured using CellQuest Pro software
on FACS Calibur Flowcytometer (BD, Biosciences; excitation,
488 nm; emission, 530 nm). For K+ efflux experiment, DMEM
media was replaced with Opti-MEM media and the cells were
incubated for 20 minutes in the presence and absence of 50 mM
potassium chloride. Following the incubation with KCl, the cells
were adsorbed with JEV for 1.5 h at 37uC and further incubated
in serum free media for 5 hrs. The protein from the total cell
extracts was used to study caspase-1 activation and release of
mature form of IL-1b and IL-18 by ELISA.
ELISA for IL-1b and IL-18
ELISAs for mouse IL-1b and IL-18 were performed on total
protein isolated from treated and mock-infected control BV-2 cells
as described earlier [55]. Briefly, a rat monoclonal anti-mouse IL-
1b antibody (MAB401; R & D Systems, Minneapolis, MN) and
goat biotinylated anti-mouse IL-1b antibody (BAF401; R & D
Systems) were used as coating and sandwich antibodies,
respectively. Streptavidin-conjugated HRP (GE healthcare) and
Tetramethylbenzidine (TMB) Substrate (Vector Labs, CA, USA)
were used for detection. The reaction was stopped by adding 50 ml
of Stop Solution (2 N H2SO4). The absorbance was read at
450 nm in a microplate spectrophotometer (Biorad, Australia) and
the concentrations were calculated using the IL-1b standard
reference curves. The IL-18 ELISA was conducted similarly and
the anti-IL-18 capture antibody (D047-3; R & D Systems) and
anti-IL-18 detection (D048-6; R & D Systems) antibodies were
used for primary and secondary incubation respectively. To make
the standard curves, the IL-1b and IL-18 mouse recombinant
proteins (R & D Systems, USA) were used.
RNA isolation and quantitative real time PCR (qRT-PCR)
After treatments, BV-2 cells were lysed and mice brain were
homogenised in Trizol reagent (Sigma Aldrich) as per the
manufacturer’s protocol. The RNA was isolated by phenol-
chloroform method as described earlier [52] and it was quantified
using spectrophotometer (GE healthcare biosciences AB, Uppsala,
Sweden). Oligonucleotide primer specific for mouse NLRP3
(forward: 59-TGC TCT TCA CTG CTA TCA AGC CCT-39,
reverse: 59-ACA AGC CTT TGC TCC AGA CCC TAT-39) ,
mouse IL-1b (forward: 59-TGG AAA AGC GGT TTG TCT -39,
reverse: 59- ATA AAT AGG TAA GTG GTT GCC -39) and
mouse IL-18 (forward: 59- TGG TTC CAT GCT TTC TGG
ACT CCT -39, reverse: 59- TTC CTG GGC CAA GAG GAA
GTG ATT -39) were procured from Sigma. For real time PCR,
cDNA was synthesised using Advantage RT-for-PCR kit (Clon-
tech laboratories, CA) and 500 ng of cDNA was used as a template
on ABI Prism 7700 sequence detection system (Applied Biosys-
tems, Foster City, CA). Power SYBR Green PCR master mix
(Applied Biosystems) was used for the experiment. The conditions
used for real time PCR have been described earlier [50,52] and
were as follows: 95uC for 3 min (1 cycle), 94uC for 20 s, 55uC for
30 s, and 72uC for 40 s (40 cycles). The dissociation curves were
generated to check for the specificity of primer annealing to the
template. The real time PCR results were then normalized to 18S
rRNA internal control and quantified using comparative Ct
method (22[D][D]Ct) [56] and analyzed using the iCycler Thermal
Cycler Software (Applied Biosystems).
Small interfering RNA (siRNA) transfection: Knockdown
experiments
ON-TARGET plus short interfering RNA (SiRNA) against
mouse NLRP3 (target: 59-GGU GAA AUG UAC UUA AAU C -
39) was ordered from the predefined SiRNA library of Dharmacon
RNAi technologies (Thermo fisher Scientific, USA). Scrambled
SiRNA (ScRNA) (sense: 59- GUG CAC AUG AGU GAG AU
UU- 39) was designed using an online SiRNA design software
(Ambion, Applied biosystems, Austin, USA) and was synthesized
by a Dharmacon RNAi technologies (Thermo fisher Scientific,
USA). 100 nM of NLRP3 SiRNA was used for transfection using
Lipofectamine RNAi max (Invitrogen, Carlsbad, CA, USA)
according to the manufacturer’s protocol. Briefly, BV-2 cells were
seeded and maintained in sets of three at 37uC and 5% CO2 and
when the cells were 70% to 80% confluent, they were transfected
in Opti-MEM for 6 hours after which fresh 10% DMEM was
added to the cells for 30 hours. The cells were then treated with 5
MOI of JEV for 1.5 h followed by incubation in serum free media
for different time points. Mock-infected control group received
only lipofectamine treatment. mRNA and protein were isolated
from these cells to analyse the levels of NLRP3, IL-1b and IL-18 as
well as caspase-1 activity.
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Caspase-1 assay
Caspase-1 activation assay was performed using caspase-1 assay
kit (Promega, WI, USA), as per the manufacturer’s protocol.
Briefly, duplicate wells of a flat bottom, black polystyrene 96 well
plate (Nunc, USA) were coated with blank, assay and negative
control reaction mixtures, prepared according to the manufactur-
er’s protocol. The assay mixture contained caspase Assay buffer,
DMSO (Sigma Aldrich), 100 mM DTT (Sigma Aldrich), 50 ml
treated cell extract and deionized H2O. The negative control
additionally consisted of 2.5 mM caspase-1 inhibitor (Ac-YVAD-
CHO) apart from the above mentioned reagents. The blank
reaction did not contain the cell extract. The AMC standard was
prepared simultaneously at various different dilutions according to
the procedure mentioned in the assay kit. Plate was covered with
parafilm and incubated at 30uC for 30 minutes. 2.5 mM of
substrate (Ac-YVAD-AMC) was added to all the wells and
incubated again at 30uC for additional 1 h. The fluorescence of
the reactions was measured at an excitation wavelength of 360 nm
and emission wavelength of 460 nm using the spectroflurometer
(Varioskan Flash multimode reader, Thermo Electron Corpora-
tion, Finland). The concentrations of the samples were calculated
using the AMC standard reference curve. For caspase-1 inhibition
experiments, BV-2 cells incubated with 5 mM caspase-1 inhibitor
Z-YVAD-FMK for 30 min prior to JEV infection.
Cytokine Bead Array (CBA)
The CBA kit (BD Biosciences, NJ, USA) was used to
quantitatively measure cytokine levels in the mock-infected control
and JEV infected BV-2 cells. Using 50 ml of mouse inflammation
standard and sample dilutions, the assay was performed according
to the manufacturer’s instructions and analyzed on the FACS
Calibur (Becton Dickinson). This method quantifies soluble
particles, in this case cytokines using a fluorescence based
detection mechanism. The beads, coated with IL-6, TNF-a and
CCL2 react with test lysates and standards, to which fluorescence
dyes are then added. Analysis was performed using CBA software
that allows the calculation of cytokine concentrations in unknown
lysates [35].
Statistical analysis
Data are represented as the mean 6 standard error of the mean
(SEM) from at least three independent experiments. The data
generated were analyzed statistically byone way analysis of
variance (ANOVA) with Bonferroni’s post hoc test using
SigmaStat 3.5 software (Systat Software Inc., San Jose, California).
A statistical p-value of 0.01 and 0.05 were considered significant.
Supporting Information
Figure S1 Replication competent JEV and not host
derived factors are responsible for caspase-1 activity.
(A) Plaque assay carried out with JEV infected mouse brain
homogenates (JEV) along with UV irradiated homogenates of JEV
infected mouse brains (UV-JEV). (B) Caspase-1 activity measured
from BV-2 cells that were treated with mock-treated mice brain
homogenates (Ctrl) as well as JEV treated mouse brain
homogenates (JEV) and JEV treated mouse brain homogenates
that are UV irradiated (UV-JEV). (C–D) ELISA study showing the
levels of IL-1b (C) and IL-18 (D) in Ctrl, JEV as well as UV-JEV
conditions. Graph represents IL-1b and IL-18 levels in pg/ml.
Data represent mean 6 SEM from 3 independent experiments
performed in duplicate. Statistical differences were evaluated using
the one way ANOVA with Bonferroni’s post hoc test. **, Statistical
difference in comparison to cells treated with control brain
homogenate (**p,0.01) and #, Statistical difference with respect
to JEV infected condition (p,0.01).
(TIF)
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